Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AzaSite in posterior blepharitis
NCT00656539Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AzaSite in posterior blepharitis, sponsored by Merck & Co.. Started Apr 2008; status: completed.
02
Drugs
AzaSite
03
Conditions
posterior blepharitis
Beyond the preview
Go deeper on NCT00656539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656539.